Copyright
©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1421-1437
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1421
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1421
Before PSM analysis | After PSM analysis | |||||
Characteristics | Platelets transfusion (n = 91) | No platelets transfusion (n = 822) | P value | Platelet transfusion (n = 89) | No platelet transfusion (n = 89) | P value |
Age (yr) | 42 (34-50) | 45 (35-54) | 0.012 | 42 (34-50) | 40 (30-50) | 0.716 |
Sex (Male:Female) | 77 (84.6): 14 (15.4) | 685 (83.3): 137 (16.7) | 0.882 | 75 (84.3): 14 (15.7) | 80 (89.9): 9 (10.1) | 0.372 |
Heart rate (per minute) | 90 (84-100) | 96 (86-110) | 0.016 | 90 (85-100) | 89 (82-100) | 0.546 |
MAP (mm of Hg) | 81 (75-87) | 82 (74-90) | 0.341 | 81 (75-87) | 81 (73-88) | 0.968 |
Hemoglobin (g/dL) | 7.7 (6.1-9.4) | 7.6 (6.1-9.4) | 0.890 | 7.7 (6.1-9.4) | 7.5 (6.3-9.0) | 0.720 |
TLC (× 109/L) | 5.6 (3.1-8.3) | 6.6 (4.0-9.4) | 0.012 | 5.6 (3.1-8.3) | 7.0 (4.4-12.0) | 0.002 |
Platelet count (× 109/L) | 40.0 (32.0-58.0) | 100.0 (63.0-139.0) | < 0.001 | 40.0 (32.0-58.0) | 81 (57-126) | < 0.001 |
INR | 1.6 (1.3-2.0) | 1.5 (1.3-1.9) | 0.266 | 1.6 (1.3-2.0) | 1.7 (1.4-2.2) | 0.402 |
Serum urea (mg/dL) | 41 (28-60) | 36 (24-64) | 0.864 | 41 (28-61) | 34 (24-69) | 0.369 |
Creatinine (mg/dL) | 0.7 (0.5-1.0) | 0.8 (0.6-1.3) | 0.003 | 0.7 (0.5-1.0) | 0.8 (0.6-1.4) | 0.040 |
Sodium (meq/L) | 140.2 (137.0-143.0) | 139.0 (135.0-142.0) | 0.023 | 140 (137-143) | 140 (135-143) | 0.529 |
Bilirubin (mg/dL) | 1.7 (0.9-3.8) | 1.6 (0.9-3.0) | 0.771 | 1.7 (0.9-3.8) | 2.4 (1.3-4.8) | 0.071 |
AST (IU/L) | 49 (34-79) | 51 (34-88) | 0.570 | 49 (34-79) | 67 (38-119) | 0.019 |
ALT (IU/L) | 32 (22-58) | 35 (23-54) | 0.905 | 32 (22-58) | 41 (30-67) | 0.029 |
Albumin (g/dL) | 3.2 (2.7-3.8) | 3.2 (2.7-3.8) | 0.897 | 3.2 (2.7-3.8) | 3.1 (2.6-3.6) | 0.355 |
CTP | 7 (6-10) | 7 (6-9) | 0.119 | 8 (6-10) | 8 (6-10) | 0.186 |
MELD | 14.6 (10.9-20.2) | 14.7 (11.1-20.3) | 0.878 | 14.6 (10.9-20.2) | 16.1 (12.5-24.1) | 0.079 |
Ascites | 59 (64.8) | 397 (48.3) | 0.003 | 59 (66.3) | 58 (65.2) | 1.000 |
HCC | 6 (6.6) | 29 (3.5) | 0.150 | 6 (6.7) | 4 (4.5) | 0.747 |
HE | 15 (16.5) | 78 (9.5) | 0.044 | 15 (16.9) | 22 (24.7) | 0.268 |
Endotherapy (yes) | 71 (78.0) | 640 (77.9) | 1.000 | 72 (80.9) | 71 (79.8) | 1.000 |
Child class | 0.210 | 0.313 | ||||
A | 33 (36.3) | 341 (41.5) | 31 (34.8) | 22 (24.7) | ||
B | 34 (37.4) | 327 (39.8) | 34 (38.2) | 37 (41.6) | ||
C | 24 (26.4) | 154 (18.7) | 24 (27.0) | 30 (33.7) | ||
Etiology | 0.824 | 0.176 | ||||
Alcohol | 38 (41.8) | 355 (43.2) | 37 (41.6) | 47 (52.8) | ||
Other | 53 (58.2) | 467 (56.8) | 52 (58.4) | 42 (47.2) | ||
RBC | 0.483 | 0.294 | ||||
0 | 49 (53.8) | 493 (60.0) | 48 (53.9) | 56 (62.9) | ||
1 | 15 (16.5) | 128 (15.6) | 14 (15.7) | 15 (16.9) | ||
≥ 2 | 27 (29.7) | 201 (24.5) | 27 (30.3) | 18 (20.2) | ||
FFP transfusion | 22 (24.2) | 86 (10.5) | < 0.001 | 22 (24.7) | 22 (24.7) | 1.000 |
Grade of varices low:high | 71 (78.0) | 714 (86.9) | 0.026 | 69 (77.5) | 84 (94.4) | 0.002 |
- Citation: Biswas S, Vaishnav M, Pathak P, Gunjan D, Mahapatra SJ, Kedia S, Rout G, Thakur B, Nayak B, Kumar R, Shalimar. Effect of thrombocytopenia and platelet transfusion on outcomes of acute variceal bleeding in patients with chronic liver disease. World J Hepatol 2022; 14(7): 1421-1437
- URL: https://www.wjgnet.com/1948-5182/full/v14/i7/1421.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i7.1421